NASDAQ:MDCX Medicus Pharma Q3 2026 Earnings Results & Report $1.85 -0.02 (-1.28%) As of 12:07 PM Eastern This is a fair market value price provided by Massive. Learn more. Medicus Pharma missed analyst earnings expectations in its Q3 2026 results, released November 6, 2026. The company reported EPS of -$11.64 versus the -$6.68 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 6, 2026TimeAfter Market ClosesConference Call DateNovember 9, 2026Conference Call11:30 AM ET Live Call not available Live Event EndedEarnings Conference CallMedicus Pharma Q3 202600:00 / 00:00Live Transcript Follow Audio Medicus Pharma EPS ResultsActual EPS-$11.64Consensus EPS -$6.68Beat/MissMissed by -$4.96One Year Ago EPSN/AEPS Beat Rate1 of last 8 quartersMedicus Pharma Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Medicus Pharma Q3 2026 Earnings FAQ Did Medicus Pharma beat earnings estimates for Q3 2026? Medicus Pharma (NASDAQ:MDCX) reported earnings of -$11.64 per share for Q3 2026, missing the consensus estimate of -$6.68. The report was announced on Friday, November 6, 2026. Medicus Pharma Earnings HeadlinesMedicus Pharma (NASDAQ:MDCX) Stock Rating Lowered by Wall Street ZenNovember 8 at 1:07 AM | americanbankingnews.comMedicus Pharma Announces Proposed $135 Million SkinJect SPAC CombinationNovember 6 at 9:55 PM | theglobeandmail.comLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, protect it. This report normally sells for $29.97, but it's available as a free download for a limited time.November 9 at 1:00 AM | Profits Run (Ad)Medicus Prioritizes CD228V as Q3 Loss NarrowsNovember 6 at 5:31 PM | tipranks.comMedicus Pharma (MDCX) Projected to Release Earnings on FridayNovember 6 at 1:57 AM | americanbankingnews.comMedicus Pharma to Present at BIO-Europe 2026November 5, 2026 | globenewswire.comSee More Medicus Pharma Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Medicus Pharma? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Medicus Pharma and other key companies, straight to your email. Email Address About Medicus PharmaMedicus Pharma (NASDAQ:MDCX). (NASDAQ:MDCX) is a life sciences company focused on acquiring, developing and commercializing pharmaceutical and medical products. The company seeks to identify therapies and healthcare technologies with potential for commercialization and works to advance them through regulatory, clinical and market-development processes. Medicus Pharma’s activities are centered on specialty healthcare markets, including pharmaceutical and medical products designed to address unmet patient and provider needs. Its business model may include licensing, acquiring or partnering around products at different stages of development, with an emphasis on building a portfolio of commercially viable healthcare solutions. The company is headquartered in Canada and is publicly traded in the United States. Detailed information about its current product portfolio, geographic operations and executive leadership is limited in the publicly available information used for this description.View Medicus Pharma ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 11/2 - 11/6IonQ's Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength RemainsThe Ugly Truth Behind SoundHound’s Q3 ResultsSandisk Shares Are Oversold: Bargain or Value Trap?Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop? Upcoming Earnings Petroleo Brasileiro S.A.- Petrobras (11/10/2026)Transdigm Group (11/10/2026)Honda Motor (11/11/2026)Franco-Nevada (11/11/2026)Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
